Cranberry powder extract standardised to 5% A-type Proanthocyanidins
KEY ACTIONS
RAW MATERIAL
CHARACTERISTIC MOLECULES
ACTION
PACs present in cranberry can promote the maintenance of a healthy urinary tract; in particular, A-type PACs counteract the adhesion of uropathogenic bacteria to the bladder epithelium.
This interaction inhibits the initial stage of infection, resulting in a beneficial preventive action in the lower urinary tract and combating the onset of common urinary tract disorders (e.g. cystitis).
RAW MATERIAL
Cranberry
Vaccinium macrocarpon Aiton is a shrub belonging to the Ericaceae family, native to North America.
The plant produces large red fruits, which are traditionally eaten as foodstuffs and mainly used to make juices with well-known disinfectantand anti-inflammatory properties.
Cranberry
Vaccinium macrocarpon Aiton is a shrub belonging to the Ericaceae family, native to North America.
The plant produces large red fruits, which are traditionally eaten as foodstuffs and mainly used to make juices with well-known disinfectantand anti-inflammatory properties.
FORMULATIONS
MacroPAC-A® is available in:
- Powder, standardised to 5% w/w A-type PACs
Oximacro® is first titrated using the BL-DMAC method to obtain the number of total PACs and then analysed by liquid chromatography coupled to mass spectrometry (HPLC-ESI-MS/MS) to assess the content of A-type PACs
